<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="162951">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01679496</url>
  </required_header>
  <id_info>
    <org_study_id>REK 2011/1951</org_study_id>
    <nct_id>NCT01679496</nct_id>
  </id_info>
  <brief_title>Fat Quality on Blood Lipids and Immune Response</brief_title>
  <acronym>NoMa</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo and Akershus University College of Applied Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Oslo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo and Akershus University College of Applied Sciences</source>
  <oversight_info>
    <authority>Norway: Regional Ethics Commitee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate blood LDL-cholesterol and level of inflammatory
      markers after intake of food items with different fatty acid composition.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Anticipated">June 2013</completion_date>
  <primary_completion_date type="Anticipated">June 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Change in LDL-cholesterol</measure>
    <time_frame>Change from baseline after 8 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Change in LDL-cholesterol when compared to control diet</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in total cholesterol</measure>
    <time_frame>Change from baseline after 8 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Change in total cholesterol when compared to control diet</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Inflammatory markers in circulation and at gene expression level in PBMC</measure>
    <time_frame>Inflammatory markers are measured at baseline and after 8 weeks intervention in circulation and at gene expression level in PBMC</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Markers of lipid metabolism at gene expression level in PBMC</measure>
    <time_frame>Markers of lipid metabolism at gene expression level in PBMC is measured at baseline and after 8 weeks of intervention</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Appetite hormones</measure>
    <time_frame>Appetite hormones is measured at baseline and after 8 weeks of intervention</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gut peptides</measure>
    <time_frame>Gut peptides are measured at baseline and after 8 weeks of intervention</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Dietary Prevention</condition>
  <arm_group>
    <arm_group_label>Food items</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Food items low in saturated fat and high in polyunsaturated fat</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control food items</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Food items containing saturated fat and polyunsaturated fat according to a traditional Norwegian diet</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Food items</intervention_name>
    <description>Food items with different fatty acid composition</description>
    <arm_group_label>Food items</arm_group_label>
    <arm_group_label>Control food items</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  hsCRP &lt; 10 mg/L

          -  total cholesterol 5-7.8 mmol/l(50-70 y)

          -  total cholesterol 5.0-6.9 mmol/l (30-49 y)

          -  total cholesterol 5.0-6.1 mmol/l (25-29 y)

          -  LDL-cholesterol at or above 3.5 mmol/l

          -  triglycerides at or lower 2.6 mmol/l

          -  BMI 20-31

          -  Stable bodyweight last 3 months.

        Exclusion Criteria:

          -  Chronic diseases

          -  fasting glucose &gt; 6.0 mmol/l

          -  increased ASAT and ALAT

          -  medications affecting lipidmetabolism and inflammation
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stine Ulven, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oslo and Akershus University College of Applied Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kirsten B Holven, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Nutrition, Institute for Basic Medical Sciences, University of Oslo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Oslo and Akershus University College of Applied Sciences</name>
      <address>
        <city>Oslo</city>
        <zip>0130</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stine Ulven, PhD</last_name>
      <email>stinemarie.ulven@hioa.no</email>
    </contact>
    <contact_backup>
      <last_name>Kirsten B Holven, PhD</last_name>
      <email>kirsten.holven@medisin.uio.no</email>
    </contact_backup>
    <investigator>
      <last_name>Stine Ulven, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <lastchanged_date>August 31, 2012</lastchanged_date>
  <firstreceived_date>August 24, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>LDL-cholesterol</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
